FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to oncology. In order to predict efficiency of anti-tumour treatment exudate from abdominal cavity is analysed. By method of filtration detoxication obtained is protein concentrate of ascitic fluid, used for extracorporal incubation with cytostatics and carrying out intraperitoneal chemotherapy. Preliminarily determined are type of structure building of solid concentrate phase and stability of systemic and subsystemic signs. Preservation of physiologically stable radial or partly radial type of phase of ascitic fluid concentrate with formation of monomorphic singularities and concretions is prognostic sign of maximal autoascitochemotherapy efficiency - complete tumour regression. Pathologically unstable irradial and circular type of protein concentrate phase with polymorphic structures of singularities and concretions determine prognosis of treatment efficiency in form of partial tumour regression. Pathologically stable structure with irradial, circulatory type and type of "double phase" without preservation of systemic signs of concretions and singularities points to correspondence to effect of tumour growth stabilisation.
EFFECT: method allows to determine prognostic criteria of anti-tumour treatment efficiency, which will allow to correct treatment in due time.
6 dwg, 6 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WITH OVARIAN CANCER | 2007 |
|
RU2352341C1 |
METHOD OF TREATING LUNG CANCER IN EXPERIMENT | 2009 |
|
RU2405595C2 |
METHOD FOR TREATMENT OF RELAPSES IN ONCOGYNECOLOGICAL PATIENTS | 2005 |
|
RU2296564C2 |
METHOD FOR CARRYING OUT ULTRASONIC DIAGNOSTIC EXAMINATION FOR DETERMINING INDIVIDUAL RESIDUAL OVARIAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2002 |
|
RU2239362C2 |
METHOD FOR TREATING OVARY CANCER | 1999 |
|
RU2163152C1 |
METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO CHEMOTHERAPY IN PATIENTS SUFFERING FROM ASCITIC FORM OF III-IV STAGE OVARIAN CARCINOMA | 1999 |
|
RU2161801C2 |
METHOD OF PREOPERATION TREATMENT OF PATIENTS WITH OVARY CANCER AT III-IV STAGES | 1997 |
|
RU2138259C1 |
METHOD FOR COMPLEX EVALUATION OF POLYCHEMOTHERAPY EFFICIENCY FOR PATIENTS WITH RECURRENT HODGKIN'S LYMPHOMA | 2016 |
|
RU2623143C1 |
METHOD FOR DRAINING ABDOMINAL CAVITY | 1999 |
|
RU2188044C2 |
METHOD FOR TREATMENT OF INOPERABLE ASCTIC FORMS OF OVARIAN CANCER | 2016 |
|
RU2624509C1 |
Authors
Dates
2011-02-20—Published
2009-09-29—Filed